J0899 Argatroban Injection HCPCS Reimbursement | OpenPayer

Summary & Overview

HCPCS J0899: Argatroban Injection for ESRD on Dialysis

HCPCS Level II code J0899 identifies the injection of argatroban (auromedics) billed per 1 mg and specifies that this product is not therapeutically equivalent to J0884. The code is clinically significant because argatroban is an anticoagulant used for patients with end-stage renal disease (ESRD) receiving dialysis, where anticoagulation management influences dialysis circuit patency and bleeding risk. Nationally, accurate coding affects billing, inventory management for dialysis providers, and payer coverage determinations for specialty injectable drugs.

Key payers referenced in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the code’s clinical context, typical sites of service, common modifiers used on claims, and the practical implications for billing in dialysis and outpatient infusion settings. The publication also summarizes available benchmarks and policy updates where present and highlights operational considerations for ordering, documentation, and claim submission.

This summary is written for a national audience and focuses on the code’s clinical meaning, billing context, and payer coverage landscape to support revenue cycle, clinical pharmacy, and dialysis operations teams.

AetnaBlue Cross Blue ShieldCigna HealthUnitedHealthcareMedicareJ0899HCPCS Level IIargatrobandialysisESRDinjectioninfusionanticoagulantdrug billing

Billing Code Overview

HCPCS Level II code J0899 describes the injection of argatroban (auromedics), not therapeutically equivalent to J0884, billed per 1 mg. The description indicates use of argatroban formulated for patients with end-stage renal disease (ESRD) on dialysis.

Service type: Parenteral anticoagulant therapy (intravenous/subcutaneous injectable medication)
Typical site of service: Dialysis facility or outpatient infusion/administration setting associated with hemodialysis care

Data not available in the input.

Clinical & Coding Specifications

Clinical Context

A 62-year-old patient with end-stage renal disease (ESRD) on maintenance hemodialysis presents for routine dialysis access anticoagulation management. The patient has a documented history of heparin-induced thrombocytopenia (HIT) and requires anticoagulation during the dialysis session. The dialysis unit pharmacist or dialysis nurse prepares and administers argatroban intravenously per physician order for anticoagulation of the extracorporeal circuit.

The clinical workflow: the nephrology team documents the indication (HIT and ESRD on dialysis) and orders argatroban dosing in mg. Nursing confirms patient identity, reviews allergies and platelet counts, verifies vascular access patency, and administers J0899 as an intravenous injection or infusion bolus according to local dialysis protocols. During dialysis, nursing monitors activated clotting times, circuit integrity, and bleeding. The dialysis session is billed using HCPCS Level II code J0899 per milligram administered, with appropriate modifiers as indicated by payer rules and clinical circumstances.

Coding Specifications

Modifier	Description	When to Use
`JW`	Drug amount discarded/not administered	When partial vial waste is discarded and payer requires reporting of discarded biologic; indicates discarded amount per payer rules.

HCPCS J7620: Albuterol and Ipratropium Nebulized, DME Administration

HCPCS-J0330-SUCCINYLCHOLINE-CHLORIDE-INJECTION-UP-TO-20-MG

HCPCS J0330: Injection, Succinylcholine Chloride up to 20 mg

HCPCS-J0875-DALBAVANCIN-INJECTION-5MG

HCPCS Level II J0875: Dalbavancin Injection, 5 mg

HCPCS-J2210-METHYLERGONOVINE-INJECTION-POSTPARTUM-HEMORRHAGE

HCPCS J2210: Methylergonovine Injection, Up to 0.2 mg

HCPCS-J2670-TOLAZOLINE-INJECTION-25MG

HCPCS J2670: Tolazoline HCl Injection, up to 25 mg

HCPCS-J1260-DOLASETRON-INJECTION-10MG-ANTIEMETIC

HCPCS J1260: Dolasetron Mesylate Injection, 10 mg

HCPCS-J1060-TESTOSTERONE-ESTRADIOL-INJECTION

HCPCS J1060: Testosterone Cypionate and Estradiol Cypionate Injection

HCPCS-J7401-MOMETASONE-SINUS-IMPLANT-10MCG

HCPCS Level II J7401: Mometasone Furoate Sinus Implant, 10 mcg

HCPCS-J2865-SULFAMETHOXAZOLE-TRIMETHOPRIM-INJECTION

HCPCS J2865: Injection of Sulfamethoxazole and Trimethoprim

HCPCS-J1180-DYPHYLLINE-INJECTION-UP-TO-500-MG

HCPCS J1180: Injection of Dyphylline, Up to 500 mg

Showing 1–10 of 991

Taxonomy Code	Specialty	Notes
`2080P0206X`	Nephrology	Nephrologists order and oversee anticoagulation during dialysis for ESRD patients.
`363L00000X`	Dialysis Facility	Facility taxonomy for outpatient dialysis units that administer infusion anticoagulants.
`367500000X`	Nurse Practitioner	NPs commonly manage dialysis medication administration and monitoring.
`363A00000X`	Hemodialysis Technician	Technicians perform dialysis treatments and assist with drug administration under supervision.
`206E00000X`	Internal Medicine	Hospitalists or internists may manage anticoagulation for inpatient dialysis sessions.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`D75.82`	Heparin-induced thrombocytopenia (HIT)	Primary indication for using argatroban instead of heparin during dialysis anticoagulation.
`N18.6`	End stage renal disease	ESRD on dialysis is the population for whom `J0899` argatroban injection is commonly administered.
`I82.409`	Acute embolism and thrombosis of unspecified deep veins of lower extremity, unspecified	Thrombotic events may necessitate therapeutic anticoagulation management adjustments in dialysis patients.
`T45.515A`	Adverse effect of heparin, initial encounter	Alternative coding when documenting an adverse reaction to heparin prompting use of argatroban.
`Z79.01`	Long term (current) use of anticoagulants	May be present when patients require ongoing anticoagulant therapy; documents chronic anticoagulation status.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`36000`	Introduction of needle and/or catheter into peripheral vein; simple (separate procedure)	Vascular access cannulation for initiation of hemodialysis before argatroban administration in outpatient or inpatient dialysis settings.
`36556`	Insertion of tunneled central venous catheter, without subcutaneous port or pump, for dialysis access, with subcutaneous port	Performed when a long-term dialysis catheter is placed; argatroban may be administered through such access during dialysis sessions.
`90935`	Hemodialysis procedure with single evaluation by a physician or other qualified health care professional, for the individual patient, for facility or hospital use; with dialysis minutes < 4 hours	Represents the hemodialysis treatment session during which argatroban anticoagulation is used; typically billed alongside the drug code.
`96365`	Intravenous infusion for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	Used when argatroban is administered as an infusion requiring infusion service reporting in certain settings.
`99070`	Supplies and materials (except spectacles), provided by physician or other qualified health care professional over and above those usually included with the office visit or procedure	Used to report ancillary supplies related to the preparation or administration of the injectable agent when payers allow.

OpenPayer